{"name":"Kartos Therapeutics, Inc.","slug":"kartos-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KRT-232","genericName":"KRT-232","slug":"krt-232","indication":"Myeloproliferative neoplasms","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"AMG 232","genericName":"AMG 232","slug":"amg-232","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"KRT-232","genericName":"KRT-232","slug":"krt-232","phase":"phase_2","mechanism":"Inhibits CDK4/6","indications":["Myeloproliferative neoplasms"],"catalyst":""},{"name":"AMG 232","genericName":"AMG 232","slug":"amg-232","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxORllEMVJSOWVhT0RwUkJ5by1wYzlqZDdqR3puOU9RNFo3aXlZWWgzaXQ4S09Vd0RwLUp2UUREWTZPdGlpLTFTTHJEbXJ0UDJIVktEQ1pDb3ZGN2pBMV9kQXROcV9IRWZ4ZEtrS3oxX0kwQlc5TVFuNzNiU1IzRlV6UnU4a0dfVjA2ODRzbmdsRlpxei1LdG1LNlNHUDFnQmk5bjdibVBwbmd0bm94di1QUU9ad0lDdE5JMUhlVDN5R29uc2pVYkZXeEJUNkVRQXBqSkFwYkpwUFc5S2RxZUI0Q1VTQkZzdTFEc2ZWVTBVSmlBR0ZLU19ueXJGV1IwYTFfbE1R?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Myelofibrosis Drug Development Surges: 40+ Pipeline Candidates Across 35+ Companies Reshape Treatment Landscape, analyses DelveInsight - Barchart.com","headline":"Myelofibrosis Drug Development Surges: 40+ Pipeline Candidates Across 35+ Companies Reshape Treatment Landscape, analyse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE15Y0dLUWNMaWRmUTRqcUw3cTE1RzlpNVNRenlJakFKQ1o1WU9KS3lFV3AxMzBITnlZM3RVbHRqRlc3amxtTmNXdXNlVjZsZk1LM0s0eEtwMVJzZw?oc=5","date":"2026-03-10","type":"pipeline","source":"Forbes","summary":"Wayne Rothbaum - Forbes","headline":"Wayne Rothbaum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZzJVb2VfTnN4TzN2V0Y4QWRmUWZWV1U2N2xEZXpsMF9FbUY4VEstSU03SG01UE9Ha1hQU2hwUzcwdWxXU2FJZ1Y2a0ZsVmRoQjdUWnM3dWIxZXhoWTBXaEV2anBINkF0WnNwUzdnVWJVYXFHV1U3MDg0SzJUTUFhQ1VyRDdxLUYzR3VWSEw4SUV1bjNHUnlkLXRILWx3YlRvMmNuSUYtbkJQQQ?oc=5","date":"2026-01-22","type":"pipeline","source":"Pharmacy Times","summary":"Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026 - Pharmacy Times","headline":"Emerging Therapeutic Strategies Transforming Myelofibrosis Care in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQcTdsYVlJVHNQZUNfejdYdU9weUR0VUlfdkNDVXBnTTJVT2RBa3g2WFNmZUJwUFNzbTVqTWVCSUZHRzMwSTFteUh4NVJDZV9wU2hsQkJaNkNxZXpTdTR5R0MtMmN2Wk1TQjcyRGM3QjQ2S211emhhYnh0bDcweXlBSTFodjFWenVCSDdqVmotSm5sblkzSDJZVzZ1OW52bjNLZ1BLQU1ad3JUM3J2bjUxRTZLbnpCVE9XUXN0WXVJTmp0TUJUVHpIdHFMYnJnRkhnQm1rdUplLUhpSTkxYXFSeDlhTmFQQnBZUTVpMVpiU0t1ODJZUHZvbFNlXzhwak5IblJpcTNEeUpQV1Q1a2Nlb3QzODE?oc=5","date":"2025-10-28","type":"pipeline","source":"PR Newswire","summary":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) | DelveInsight - PR Newswire","headline":"CAR T-cell Therapy Market Forecasts Indicate Strong Growth Trajectory in the 7MM During the Forecast Period (2025-2034) ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFB1Zlo3VW5oRkFDck1VdG1oeXRVRll4cEpCWkhra1FfSXNDLUdpcTl5bmw3WTRRWWRxc1BfLUY2UFRNUWs1QUZMNDhpU2pvYi1Cb19j?oc=5","date":"2025-09-23","type":"deal","source":"FirstWord Pharma","summary":"Illumina to develop KRAS companion diagnostics with multiple pharma partners - FirstWord Pharma","headline":"Illumina to develop KRAS companion diagnostics with multiple pharma partners","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxPOEJzQW5qZTRBalY2QXdJanVieVVNSngta1phZ3UtTEpRZjJMY2hJcjBiXzVGWFh4NU5hMnkySmxiUUJLSlJ6ZEpsWmlweExLY1Bma2pJQV9HTElicHhvOEU5bjM5V3IyU1h1RmNuSHVHMGlfU3JkY3E2WUFIZ3dkTDBEY0xxX04xc1dIZ2lOQWp3OWZZTWdOMU04LUVOU2NqdXFIMjAtQ3lmc1F1Q2tzNTlqTEtXVnd5R0dmTkdvekUxdkhlampENGp1eU1qcmxWRk83eFZLQVluazdvNU1uR1VZZ1dCRjFs?oc=5","date":"2025-09-03","type":"pipeline","source":"PR Newswire","summary":"Myelofibrosis Market is Going to Grow at a CAGR of 9% in the Next Ten Years (2025-2034) | DelveInsight - PR Newswire","headline":"Myelofibrosis Market is Going to Grow at a CAGR of 9% in the Next Ten Years (2025-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE80bHVBdTd4bEI1dkk3bUp4UzhfUVpYU1NjVTY4LWRELTBNR2dmRWJ6UEpnNXNOZzVOREwxemtqSjVHZGhBOEhVWEJZWkFpaWZHbmpVYWhxSmpJdl9ZMVF3T0NFc3JGdkk?oc=5","date":"2025-06-02","type":"pipeline","source":"MedPage Today","summary":"Rusfertide Reduces Need for Phlebotomy in Polycythemia Vera - MedPage Today","headline":"Rusfertide Reduces Need for Phlebotomy in Polycythemia Vera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQNzczWXhHaENxQ2FYNGZOakstMm5kSzl3cUlkWHdON1ZieXY3eW9aZTRaYWdKSkRvNjJuMUZCaTZNWE5ORGthUERLM2dqemczQVcyS21vb3k2b1JrR2JuaC00TnF4aWFoRDNSQTZNUUVfY2ZYQk05RXp1T3Bud3NRazdhdFBDYm1tSWE3OU9mRzFpUml3Um91N25aVEpJZlRwS2h5bV81dw?oc=5","date":"2025-05-04","type":"pipeline","source":"The Business Journals","summary":"Billionaire investor sells oceanfront home lot for $22 million - The Business Journals","headline":"Billionaire investor sells oceanfront home lot for $22 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9OVkhibEsyOG9od3BXSTE5TmJwWXdJUHk1TnRIVlRXZ2l5Vkd6VlRzN2N6OW5HbW5IZlBaZkNkcWVieUFlZHNmTm1UV0RWUVUwREV6TmduRkg1Z2l2aG5GWTIzNGZ6dlZvMVRlWkF5X0RzQQ?oc=5","date":"2025-04-11","type":"trial","source":"Oncology Pipeline","summary":"Another false dawn for p53 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Another false dawn for p53 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOb0Z3NVJJR3A5aVJlZlFjRHh6YU1QcGtMd0J3bGJlZk50TWNmdHJLRzBPYnREX2ZBMEVTcEdGY3pCN05SVlBIbGpJYWVreTY1YjJ5VG1EVktwTWV0T3dERnB6OUZaN1dLbXh1OWpzaGpEMTlXVUN3UHh2NHM4QW5meE00NzAtLWRPSTFMQUkxQW5uQ3B1SmtMSE5nVWduTXZTcVNsc1VseDFDVFE2Ujc5NmJzc0JEbHVuXzNwWDNXaGlKeV9hTzFzcGk0X29yR0JZengwcGpZZWNfbExHaGRBT252aWZPX2hjZkE?oc=5","date":"2025-01-28","type":"pipeline","source":"BioSpace","summary":"Chronic Myeloid Leukemia Market Size to Reach USD 8.9 Billion by 2035, impelled by Advancements in Targeted Therapy - BioSpace","headline":"Chronic Myeloid Leukemia Market Size to Reach USD 8.9 Billion by 2035, impelled by Advancements in Targeted Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOVEhwWkFnNEFxT0VNNnZreGlTRzVBSEVzUmRDVUxsdGx3QTdYRXlVck9KRzYwU1FoVGc2NXJjUW1rNXRKaDNKMUJRVzRreE4xeVlZdmh5YkZXNFFGeEJPNUlOeGJFTGpsRjFqOWh1Zlk3VXR1eWdKNGpJSkg3RXozTUpldmxkRHhxT3Y4YnFoYmNoa0h6NkIzTHR2RFZGbTNQeFJVbA?oc=5","date":"2023-03-03","type":"regulatory","source":"Fierce Biotech","summary":"Chutes & Ladders—Billy Dunn departs FDA neuroscience team after 18 years - Fierce Biotech","headline":"Chutes & Ladders—Billy Dunn departs FDA neuroscience team after 18 years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNY241VmFsYmxuaWlWd2NZVVlNa1dXQUZFNDUzX21MYTZPQUEtMkhRX0lBSG5rVV9Cc1lKZWdGX3dFZjE4VVZOQVBnNm9DLV8ybEp4bU8xbEJhanY3V2dSUVZmVFFVZzhlUDdIQzAyNTNaUnhRZzhvLXI2OUJFSUdBOWd4dlgwbFBKUEZoZWl0emNhSmNoYWotcVBhVG9BZnAtYnc3bUg2T2p0bnJHcFFxMkw4YW81RGF0S3VCalhCNUdpLVY5WVZ3cHFnUQ?oc=5","date":"2023-03-02","type":"pipeline","source":"Business Wire","summary":"Kartos Therapeutics Appoints Dr. Srdan Verstovsek as Chief Medical Officer - Business Wire","headline":"Kartos Therapeutics Appoints Dr. Srdan Verstovsek as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}